Find your next read.

An ABR benchmark asks two different questions about its labels

A historical methods account examines how one paper separates learning a label from being evaluated against it.

AccessGUDID flags do not supply production-identifier values

FDA’s catalog stores one portion of a UDI and flags attributes of another.

OtoCompanion’s record describes an adjunctive image-analysis workflow

A September clearance describes pediatric middle-ear-fluid software with a clinician retained in the workflow.

Language settings and assisted testing shape a hearing-app study’s protocol

A historical study separates the app’s selected language, delivered test language and help given to participants.

The geography behind a Medicare hearing-services study

A county’s billed services and its residents’ use of care are different measurements.

What a Medicare group listing establishes

CMS assigns different roles to clinician, enrollment and group identifiers.

Wastewater sites and patient populations use different boundaries

CDC’s documentation distinguishes community sampling from counts of people and identifies gaps in the geography that monitoring represents.

A fungal editorial’s rhinitis example is a community comparison

A gut-community comparison sits within a broader discussion of fungal infection and treatment.

SEER preprint separates emotion labels from intensity labels

Its reference-selection method uses emotion supervision and simulated implant processing.

Preprint proposes single-voice EEG attention tracking

The abstract specifies inputs and labeling assumptions; full methods remain unappraised.

SoundBubble-EEG preprint uses simulated listening scenes

An auditory-attention EEG preprint uses laboratory scenarios and a fixed block order.

What “dry” and “wireless” mean in an ultrasonic earpiece preprint

A prototype separates an acoustic ear interface from its control link, while its authors leave physiological testing for future work.

Dataset issued: Jun 30, 2026 ↗

Food and beverage: 87.8% of records, 19.2% of value in one 2025 disclosure cohort

The cohort includes only CMS general-payment records whose first reported specialty exactly matches the otolaryngology label.

Bicara’s study record adds six coded U.S. entries

The registry list grew from one entry to seven between retained observations; generic site codes leave institutional identities and activation dates unresolved.

Release notes dated: Mar 16, 2026 ↗

CDC’s 2023 county hearing estimates differ by 1.6 points at the median

The analysis compared 2,956 county pairs from the 2023 hearing cohort, giving every county equal weight.

Framework effective: Sep 10, 2026 ↗

FDA’s September 10, 2026 ENT order codified a 2023 decision

FDA’s September 2026 codification and Galen’s July 2023 grant answer different regulatory questions.

Preprint tests speaker video in experimental hearing-aid processing

The laboratory model combines speaker video and an audiogram with audio; wearable processing remains unresolved.

Reading CDC’s respiratory categories and ED shares

Broad illness categories and virus-specific emergency-department shares answer different questions. CDC’s public documentation explains why their labels need separate context.

What FDA recall classes and status tell an ENT practice

A useful briefing keeps the hazard category, recall progress and exact product identifiers beside the action described in the notice.

The five-year clock behind ACS hearing estimates

Census guidance supports a specific 2020–2024 versus 2015–2019 comparison, with definitions and methodological cautions that belong beside the numbers.

The gap between NeuroToken’s trial decisions and changing attention

The September preprint combines several decoding tasks. Its stated limitations leave changing attention and clinical use outside the demonstrated scope.

How to read Open Payments in ENT reporting

CMS separates the reporting year from the publication cycle. A disclosure also needs context before it can support a claim about a relationship.

How to read an organization NPI in ENT business reporting

CMS documentation explains the identifier and the reported data behind it. Practice operations and business relationships require their own evidence.

Why MAUDE report counts are not device-risk rates

For ENT-device readers, the key checks are what a chart counted, the missing device-use denominator and whether the evidence supports a comparison.

References observed: Oct 14, 2026 ↗

How to separate registry updates from study results

ClinicalTrials.gov posting dates, recruitment labels and results dates describe different milestones. Here is how to keep them separate.

References observed: Oct 14, 2026 ↗

How to read FDA device milestones in ENT news

FDA's process descriptions distinguish staged PMA submissions, Breakthrough designation and a marketing decision. Each establishes something different.

Release notes dated: Mar 16, 2026 ↗

How to read CDC’s county hearing estimates

The December 2025 PLACES release uses 2023 hearing-survey inputs. Its definition, model, estimate type and missing states set the limits of a county percentage.

Framework effective: Oct 17, 2022 ↗

The adult boundary in FDA's OTC hearing-aid category

The category introduced in 2022 defines intended users and access. Evaluating a particular product requires separate evidence.